Tonlamarsen for Acute Severe Hypertension

Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension

Recruiting Phase 2 Interventional Study
Hypertension Acute Severe Hypertension Hypertensive Emergency Hypertensive Urgency
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
140 (estimated)
Sponsor
Kardigan, Inc. · Industry
Who this trial is looking for

This trial is looking for adults who have recently been hospitalized for severe high blood pressure. Participants will take a medication called tonlamarsen to see how well it lowers their blood pressure.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 18 or older
  • I weigh at least 50 kg
  • I have been discharged from the hospital within the last 7 days
  • I had a blood pressure reading of 180/110 mmHg or higher
  • My average resting office blood pressure is at least 145 mmHg
  • I have cardiovascular or kidney disease

You may not be able to join if

  • I have a known history of secondary hypertension
  • I have had cancer that needed treatment in the last 5 years
  • I have significant thyroid problems
  • I was recently hospitalized for a stroke or heart attack
  • I have signs of serious liver disease
  • My liver enzyme levels are more than twice the normal limit
  • My last hospitalization was for a non-heart or non-kidney issue

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

The purpose of this study is to evaluate the blood pressure-lowering effect of tonlamarsen in adult participants who were recently hospitalized and concurrently experienced an episode of acute severe hypertension.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Key Inclusion Criteria: * Age 18 or older, body weight ≥ 50 kg with BMI ≤45.0 kg/m2 * Ready for discharge or recently discharged from the hospital to home (within the past 7 days) during which evaluation and/or treatment of acute severe hypertension (documented SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg)…
Contacts

Kardigan Clinical Study Information Team

+1-877-310-5135

clinicaltrials@kardigan.bio

CONTACT